Our research

We have a bold ambition: to stop prostate cancer limiting men's lives. And it’s through funding research that we will make this happen.

This goal is underpinned by our research strategy, which sets out how we invest in the most innovative ideas to accelerate improvements for men. Specifically, we focus on funding research in three key areas: better diagnosis, better treatments and smarter data. By tackling these areas, we can make the biggest impact to men with, or at risk of, prostate cancer.

Hot topics in research

What we're most excited about

For researchers

Applications and funding

Our clinical research

Our clinical trials have already helped make significant advances in clinical practice, for example contributing to the evidence that proved a new imaging technology, called mpMRI, could be used to transform prostate cancer diagnosis. And we’ve got many more where that came from.

On the map below, you can find all our clinical studies that are open for recruitment. If you’d like to find out more about any of these studies, follow the link to the dedicated page. And if you’re interested in taking part in any of our funded trials, speak to your medical team, or contact our Specialist Nurses on 0800 074 8383 for more information on what it means to be part of a clinical trial.

We try to keep this map as up to date as possible, but there may be times when some of the marked recruitment sites are no longer open. Speak to your medical team, or our Specialist Nurses, for the most up to date information on the trials that may be suitable for you.  

Learn more about our clinical research

Latest news from prostate cancer research

Research Innovation Awards: Focus on advanced disease as we invest £2.8m

From a pioneering new drug about to hit clinical trials, to a revolutionary home urine test for prostate cancer, here's the projects we're funding in this round of Research Innovation Awards.

Read more

After ten years working on a new treatment for men, this researcher is at a critical point

Simon Mackay's innovative new drug needs an extra push so it can be tested in clinical trials.

Read more

As prostate cancer deaths hit all-time high, we renew our MANifesto

Today we renew our MANifesto and call for fresh support for our movement in response to new data showing prostate cancer deaths hit a record high of 12,000 in one year.

Read more